Role of paraventricular nucleus vasopressin V1A receptors in the response to endothelin 1 activation of the subfornical organ in the rat

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 8, 2008, Pages 47-59

  Rossi, Noreen F ^a   Maliszewska Scislo, M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Hemodynamics; Rat; Renal sympathetic nerve activity

Indexed keywords

ENDOTHELIN 1; NEUROTRANSMITTER; VASOPRESSIN V1A RECEPTOR; ENDOTHELIN A RECEPTOR; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; BRAIN NERVE CELL; BRAIN REGION; CANNULATION; CONFERENCE PAPER; HEART RATE; HEMODYNAMIC PARAMETERS; INTRAVASCULAR CATHETER; KIDNEY NERVE; MAGNOCELLULAR NUCLEUS; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; NERVE CONDUCTION; NONHUMAN; PRESSOR RESPONSE; RAT; SPRAGUE DAWLEY RAT; SUBFORNICAL ORGAN; SYMPATHETIC NERVE; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN RELEASE; WAKEFULNESS; ADRENERGIC SYSTEM; ANIMAL; ANTERIOR HYPOTHALAMUS; ARTICLE; BLOOD PRESSURE; DENDRITE; DRUG EFFECT; INNERVATION; KIDNEY; METABOLISM; SECRETION;

ANIMALS; BLOOD PRESSURE; DENDRITES; ENDOTHELIN-1; HEART RATE; KIDNEY; MALE; MICROINJECTIONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, VASOPRESSIN; SUBFORNICAL ORGAN; SYMPATHETIC NERVOUS SYSTEM; VASOPRESSINS;

EID: 63649090296     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989; 86: 7285-7289. (Pubitemid 19240911)
2. Takahashi K, Ghatei MA, Jones PM, et al. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endo Metab 1991; 72: 693-699. (Pubitemid 21921750)
3. Wall KM, Ferguson AV. Endothelin acts at the subfornical organ to influence the activity of putative vasopressin and oxytocin-secreting neurons. Brain Res 1992; 586: 111-116.
4. Yamamoto S, Inenaga K, Eto S, Yamashita H. Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. Obesity Res Suppl 1995; 5: 789S-794S.
5. Yoshizawa T, Shinmi O, Giaid A, et al. Endothelin: a novel peptide in the posterior pituitary system. Science 1990; 247: 462-464. (Pubitemid 20044638)
6. Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, Uemura H. Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 1993; 132: 530-533. (Pubitemid 23056103)
7. 125I]endothelin in rat and human brain. Neurosci Lett 1989; 97: 276-279.
8. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 1989; 256: R858-R866. (Pubitemid 19122707)
9. Miselis RR. The efferent projections of the subfornical organ of the rat: a circumventricular organ within the neural network subserving water balance. Brain Res 1981, 230: 1-23. (Pubitemid 12253665)
10. Rossi NF, O'Leary DS, Chen H. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion. Am J Physiol 1997; 272: E126-E132. (Pubitemid 27066650)
11. Kuwaki T, Cao W-H, Kumada M. Endothelin in the brain and its effect on central control of the circulation and other functions. Jap J Physiol 1994; 44: 1-18. (Pubitemid 24126740)
12. Gulati A, Rebello S, Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol 1997; 273: H1177-H1186. (Pubitemid 27418814)
13. Nishimura M, Takahashi J, Masusawa M, et al. Chronic intracerebroventricular infusions of endothelin elevate arterial pressure in rats. J Hypertension 1991; 9: 71-76.
14. Yamamoto T, Kimura T, Ota K, et al. Central effects of endothelin 1 on vasopressin and atrial natriuretic peptide release and cardiovascular and renal function in conscious rats. J Cardiovasc Pharmacol 1991; 17: S316-S318.
15. Rossi NF, Chen H, Musch TI. Endothelin 1-induced pressor response and vasopressin release in heart failure. J Cardiovasc Pharmacol 2002; 40: 80-89. (Pubitemid 34705534)
16. Spieker LE, Noll F, Rushchitzka FT, Lusher TF. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol 2001; 37: 1493-1505. (Pubitemid 32385980)
17. Spinarova L, Spinar J, Vasků A, et al. Big endothelin in chronic heart failure: marker of disease severity or genetic determination. Int J Cardiol 2004; 93: 63-68. (Pubitemid 38068511)
18. Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 1981; 305: 263-266 (Pubitemid 11087371)
19. Arai M, Yoguchi A, Iso T, et al. Endothelin-1 and its binding sites are upregulation in pressure overload cardiac hypertrophy. Am J Physiol 1995; 268: H2084-H2091.
20. McConnell PI, Olson CE, Patel KP, et al. Chronic endothelin blockade in dogs with pacing-induced heart failure: Possible modulation of sympathoexcitation. J Cardiac Failure 2000; 6: 56-65. (Pubitemid 30161418)
21. Rossi NF, Maliszewska-Scislo M, Chen H. Central endothelin: effects on vasopressin and the arterial baroreflex in doxorubicin heart failure rats. Can J Physiol Pharmacol 2008; 86: 343-352
22. Pacher R, Stanek B, Hulsmann M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-641. (Pubitemid 26081922)
23. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-585. (Pubitemid 29384167)
24. Pow DV, Morris JF. Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 1989; 32: 435-439. (Pubitemid 20003259)
25. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 1998, 10: 881-895. (Pubitemid 28544798)
26. Ludwig M, Pittman QJ. Talking back: dendritic neurotransmitter release. Trends Neurosci 2003; 26: 255-261. (Pubitemid 36556156)
27. Ludwig M, Callahan MF, Neumann I, Landgraf R, Morris M. Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J Neuroendocrinol 1994; 6: 369-373. (Pubitemid 24254234)
28. Gouzenes L, Desarmenien MG, Hussy N, Richard P, Moos FC. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular neurons J Neurosci 1998; 18: 1879-1885. (Pubitemid 28103095)
29. Sabatier N, Richard P, Datanithi G. Activation of multiple intracellular transduction signals by vasopressin in vasopressin-sensitive neurones of the rat supraoptic nucleus. J Physiol (Lond) 1998; 513: 699-710. (Pubitemid 29008102)
30. Gillard EF, Coburn CG, de Leon A, et al. Vasopressin autoreceptors and nitric oxide-dependent glutamate release are required for somatodendritic vasopressin release from rat magnocellular neuroendocrine cells responding to osmotic stimuli. Endocrinol 2007; 148: 479-489. (Pubitemid 46143152)
31. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviors. Nature Rev Neurosci 2006; 7: 126-136. (Pubitemid 43151599)
32. 1a receptor messenger ribonucleic acid in adult male rat brain, pineal and brain vasculature. Endocrinol 1994; 135: 1511-1528.
33. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 2000; 100: 549-556.
34. Maliszewska-Scislo M, Scislo T, Rossi NF. Effect of endogenous angiotensin on baroreflexes in conscious streptozotocin diabetic rats. Am J Physiol Heart and Circ 2003; 284: H1601-H1611. (Pubitemid 36460772)
35. Moos F, Freund-Mercier M, Guerne Y, Guerne J, Stoekel M, Richard P. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J Endocrinol 1984; 102: 63-72. (Pubitemid 14123921)
36. Mason WT, Hatton GI, Ho YW. Central release of oxytocin, vasopressin and neurophysin by magnocellular neurone depolarization: evidence in slices of guinea pig and rat hypothalamus. Neuroendocrinology 1986; 42: 311-322. (Pubitemid 16126937)
37. Ludwig M, Leng G. Autoinhibition of supraoptic nucleus vasopressin neurons in vivo: a combined retrodialysis/electrophysiological study in rats. Eur J Neurosci 1997; 9: 2532-2540. (Pubitemid 28082942)
38. Wotjak CT, Ganster J, Kohl G, Holsboer F, Landgraf R, Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998; 85: 1209-1222. (Pubitemid 28293425)
39. Swanson LW. Immunohistochemical evidence for a neurohypophysin-containing autonomic pathway arising in the paraventricular nucleus of the hypothalamus. Brain Res 1977; 128: 356-363.
40. Swanson LW, Kuypers HGJM. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double labelling methods. J Comp Neurol 1980; 194: 555-570. (Pubitemid 11197739)
41. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983; 6: 269-324.
42. Malpas SC, Coote JH. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. Am J Physiol Reg Integr Comp Physiol 1994; 266: R228-R236. (Pubitemid 2045848)
43. Gilbey MP, Coote JH, Fleetwood-Walker S, Peterson DF. The influence of the paraventriculospinal pathway, and oxytocin and vasopressin on sympathetic preganglionic neurons. Brain Res 1982; 251: 283-290. (Pubitemid 13230303)
44. Lovick TA, Coote JH. Electrophysiological properties of paraventriculo-spinal neurons in the rat. Brain Res 1988; 454: 123-130. (Pubitemid 18159780)
45. Takeda K, Nakata T, Takesako T, et al. Sympathetic inhibition and attenuation of spontaneous hypertension by PVN lesions in rats. Brain Res 1991; 543: 286-300.
46. Rossi NF, Chen H. Paraventricular nucleus lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin. Am J Physiol 2001; 280: E349-E356. (Pubitemid 32479665)
47. Zhu B, Herbert J. Behavioral, autonomic and endocrine responses associated with c-fos expression in the forebrain and brainstem after intracerebroventricular infusions of endothelins. Neuroscience 1996; 71: 1049-1062. (Pubitemid 26090018)
48. Rossi NF, Chen H. Aminopropionic acid receptors in paraventricular nucleus mediate pressor and vasopressin responses to endothelin 1 in subfornical organ. Exp Biol Med 2006; 231: 1075-1080. (Pubitemid 43845581)
49. Ludwig M, Bull PM, Tobin VA, et al. Regulation of activity dependent dendritic release from rat supraoptic neurons. J Physiol (Lond) 2005; 564: 515-522. (Pubitemid 40585050)
50. Landgraf R, Neumann ID. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 2004; 25: 150-176. (Pubitemid 39642188)